Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
May 02, 2024 17:00 ET
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
RGC Resources, Inc. Declares Quarterly Dividend
May 02, 2024 17:00 ET
|
RGC Resources Inc.
ROANOKE, Va., May 02, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of RGC Resources, Inc. (NASDAQ: RGCO), at its meeting on May 1, 2024, declared a quarterly dividend of $0.20 per share on the...
Descartes Sets Date to Announce First Quarter Fiscal 2025 Financial Results
May 02, 2024 17:00 ET
|
The Descartes Systems Group Inc.
WATERLOO, Ontario, May 02, 2024 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report...
The Tile Shop to Host First Quarter 2024 Earnings Conference Call
May 02, 2024 16:47 ET
|
Tile Shop Holdings, Inc.
MINNEAPOLIS, May 02, 2024 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (the “Company”), a specialty retailer of natural stone, man-made and luxury vinyl tiles, setting and maintenance...
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2024 16:37 ET
|
Olema Oncology
SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Host Hotels & Resorts Provides Updated First Quarter 2024 Investor Presentation
May 02, 2024 16:30 ET
|
Host Hotels & Resorts, L.P.
BETHESDA, Md., May 02, 2024 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, today provided an updated...
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
May 02, 2024 16:30 ET
|
Cellectis Inc.
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules
May 02, 2024 16:30 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cellectis nomme Arthur Stril directeur financier par intérim
May 02, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, 02 mai 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) (la « Société »), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière...
Greenlight Capital Re, Ltd. Schedules First Quarter 2024 Financial Results and Conference Call
May 02, 2024 16:25 ET
|
Greenlight Capital Re
GRAND CAYMAN, Cayman Islands, May 02, 2024 (GLOBE NEWSWIRE) -- Greenlight Capital Re, Ltd. (NASDAQ: GLRE) (the "Company" or "Greenlight Re"), a multiline property and casualty insurer and reinsurer,...